Bergmann enema to prevent radiation injury in rectal cancer
Part of Cancer, Digestive system clinical trials.
This trial tests whether giving an enema (a liquid medicine inserted into the rectum) called Bergmann can help prevent rectal injury caused by radiation therapy in patients with rectal cancer. If you are about to start short-course radiation, this treatment might reduce side effects like pain or bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You need a confirmed diagnosis of rectal cancer in the lower part of the rectum (mid-lower rectal cancer).
- You are scheduled to receive short-course radiation therapy to the pelvis (5 doses over 5 days).
- You should be in generally good health (able to care for yourself) and expected to live more than 6 months.
- You have not had pelvic radiation before, are not pregnant or breastfeeding, and have no severe allergies or bowel blockage.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving a steroid medication (dexamethasone) as an enema can help reduce the side effect of radiation treatment on the rectal area. If you are getting radiation for rectal cancer and are bothered by rectal irritation, this might be a helpful addition to your care.
This trial tests whether a special dietary supplement can help protect the rectum from radiation damage during chemoradiation for locally advanced rectal cancer. If it works, it may reduce painful bowel symptoms like frequent stools and cramping.
This trial tests a dietary supplement to help heal damage inside the rectum caused by pelvic radiation therapy. If you have mild to moderate rectal bleeding but no signs of cancer recurrence, you may be able to join.
This trial tests a shorter radiation course combined with two chemotherapy drugs and an immunotherapy drug for people with locally advanced rectal cancer that is microsatellite stable. The goal is to shrink the tumor before surgery, which may improve outcomes with fewer side effects.
This trial studies a special type of radiation therapy for older adults with rectal cancer who are not able or willing to have surgery. It combines external beam radiation with a short, focused radiation treatment inside the rectum (brachytherapy) to try to control the cancer while avoiding the risks of surgery.
This trial tests a shorter course of radiation to the pelvis to treat rectal cancer, with the goal of avoiding surgery and preserving the rectum. It may be an option for people with advanced rectal cancer that has not spread to other organs.
Hear when a new Acute Radiation Enteritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.